RecallDepth
Class I Terminated

Mirtazapine Tablets, USP, 15 mg, 500-count tablets, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810 NDC 13107-031-05

Company
Auromedics Pharma Llc
Recall Initiated
November 20, 2019
Posted
December 18, 2019
Recall Number
D-0636-2020
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
East Windsor, NJ, United States

Reason for Recall

Labeling: Label Error on Declared Strength; cases labelled Mirtazapine 15mg tablets, 500-count bottles, contain 500-count bottles of Mirtazapine 15mg tablets labelled as Mirtazapine 7.5 mg tablets.

Distribution

Nationwide

Lot / Code Info

Lot #: 03119002A3, Exp 3/2022

More recalls by Auromedics Pharma Llc

View all recalls by this company →

Other recent Class I Drug recalls